HOME >> MEDICINE >> NEWS
Herbal supplements' testing topic of discussion at chemistry meeting March 30

ts in the United States:Mingfu Wang, Department of Plant Biology and Pathology, Rutgers University, New Brunswick, N.J., will discuss the quality of a variety of botanicals used in beverages, dietary supplements, foods, healthcare and personal care products. Even for standardized botanical extracts, he says, many quality problems exist. Often, he says, quality control standards are lacking or nonexistent. (AGFD 118, Wednesday, March 31, 10:15 a.m.)
  • Regenerative properties of Chinese herbs:Rong-Tsun Wu, Ph.D., Research Center for Drug Discovery & Institute of Biopharmaceutical Science, Yang-Ming University, Taipei, Taiwan, will highlight a wide range of Chinese herbs to treat a broad range of conditions. Among these are anti-aging herbs and those used to treat dementia and help maintain normal eyesight. Still others are used as an adjunct to cancer chemotherapy, to repair brain damage and prevent osteoporosis. ( AGFD 133, Wednesday, March 31, 3:50 p.m.)


'"/>


30-Mar-2004


Page: 1 2

Related medicine news :

1. Herbal extract as effective as commonly prescribed anti-depressant
2. Herbal, nutritional supplements linked to ocular side effects
3. Herbal weight-loss product information can be misleading
4. Herbal dietary supplement alters metabolism of chemotherapy drug
5. Herbal assisted weight loss causes neurological ailment in woman
6. Herbal extract is an effective treatment for hay fever
7. UCSF Study Shows That An Herbal Therapy Reduces PSA Levels By Half In Men With Advanced Prostate Cancer
8. Preliminary Study Proves Centuries Of Herbalists Right About Echinacea
9. UCSF Recruting Breast Cancer Patients For Herbal Therapy Study
10. HIV testing should be routine part of primary health care for sexually active
11. HIV testing should no longer be accorded any special status

Post Your Comments:
(Date:5/26/2015)... CA (PRWEB) May 27, 2015 ... beautiful technology for women, today announces the ... monitors women’s stress, sleep, activity and ovulation. The ... with innovative health tracking technolo- gy, particularly its ... levels, to provide women with lifestyle data and ...
(Date:5/26/2015)... May 27, 2015 Securityhunter ... (MATOC) by the United States Department of Health and ... The MATOC was awarded through the General ... (FSS) for the PSC, which is a fee-for-service agency. ... one year options, and is an enterprise–wide physical security ...
(Date:5/26/2015)... (PRWEB) May 27, 2015 This summer, ... connecting with local communities at key events in Greater Boston ... supplied with free copies of ChopChop Magazine, healthy snacks and ... to stay active. , “We want to get our message ... out in a memorable and fun way,” explains Sally Sampson, ...
(Date:5/26/2015)... 26, 2015 Mr. Gould and Mr. Ken ... start working together this week to ensure a smooth transition. ... healthcare executive leadership and strategy. Gary is familiar with ... hiring of Mr. Cochran. The Board of Trustees believe Mr. ... improvement strategies implemented over the past few years. , ...
(Date:5/26/2015)... May 26, 2015 The federal court ... filed on behalf of individuals who were allegedly injured ... June 11th Science Day. According to an Order issued ... on May 21st, topics to be addressed include Xarelto ... use of blood test based testing with Xarelto, and ...
Breaking Medicine News(10 mins):Health News:Bellabeat debuts the LEAF - smart jewelry that monitors women’s health. 2Health News:Bellabeat debuts the LEAF - smart jewelry that monitors women’s health. 3Health News:Securityhunter Has Been Awarded a Multiple Award Task Order Contract (MATOC) by the Department of Health and Human Services 2Health News:Award-Winning Cooking Magazine for Kids Takes Healthy Cooking and Eating to the Streets with One-of-a-Kind Bike Campaign 2Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 2Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 3Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 4
(Date:5/26/2015)... -- OrthoAccel ® Technologies, Inc., the leader in non-invasive, accelerated ... response to continued demand from orthodontists and patients for ... practice locations in the U.S. and Canada ... is the only FDA-cleared Class II medical device that ... as much as 50 percent.  A ...
(Date:5/26/2015)... 2015 Aethlon Medical, Inc. (OTCQB: AEMD), ... address infectious diseases and cancer, today announced that ... will present at the SeeThruEquity 4th Annual Microcap ... Aethlon Medical,s presentation are as follows:Event: , SeeThruEquity ... May 28, 2015Time: , 8:00 a.m. Pacific Time ...
(Date:5/26/2015)... -- ViiV Healthcare, Aurobindo Pharma, and the ... Aurobindo Pharma has submitted an Abbreviated New Drug Application ... Food and Drug Administration (FDA), for the treatment of ... version of dolutegravir, less than two years after FDA ... the United States . Upon receiving ...
Breaking Medicine Technology:OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 2OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 3Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 2Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 3Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7
Cached News: